Case Report
Published on 27 May 2025
Telitacicept as double-targeted therapy for myasthenia gravis coexisting with connective tissue disease: three case reports
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1552521
- 3,508 views

